Table 2.

End-organ activity at baseline (Cycle 2) on a cyclic low dose regimen (20mcg EE/100mcg LNG) and following randomization to either a continuous low dose regimen or cyclic dosing with an increased dose of an OC (30mcg EE/150mcg LNG).

Study group	CC group		ID group
Cycle	Cycle 2	Cycle 4	Cycle 2	Cycle 4
Maximum follicular diameter*
≥8 mm	13	8	10	8
≥10 mm	11	4	8	4
≥13 mm	9	3	7	3
≥18 mm	8	2	5	1
Peak cervical mucus score
0–4	9	8	8	11
5–8	6	6	7	3
9–12	1	2	0	1
E2 > 75pg/mL	10	2	6	3
Progesterone >3ng/mL	1	0	0	0
Active follicle-like structure**	9	2	5	1

^*Numbers are cumulative

^**E2>75pg/mL + Maximum follicular diameter >10